NRAS and neoplasm: Since mutant NRAS is known to drive glutamine dependency in melanoma17, we investigated the effect of glutamine supplementation in HMCB xenografts, which express wild-type BRAF and mutant NRAS, and found that increased glutamine intake hindered growth in these tumours compared to the control diet group (Supplementary Fig. 1a, b).